Health care provider recommendation, human papillomavirus vaccination, and Race/Ethnicity in the US national immunization survey

American Journal of Public Health

Volumn 103, Issue 1, 2013, Pages 164-169

  Ylitalo, Kelly R ^a,d   Lee, Hedwig ^b   Mehta, Neil K ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c EMORY UNIVERSITY   (United States)

^d not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; CAUCASIAN; CROSS-SECTIONAL STUDY; ETHNIC GROUP; ETHNOLOGY; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HISPANIC; HUMAN; IMMUNOLOGY; INSURANCE; NEGRO; PAPILLOMAVIRUS INFECTION; PRACTICE GUIDELINE; PREVALENCE; RACE; SOCIAL CLASS; STATISTICS; UNITED STATES; VACCINATION;

ADOLESCENT; AFRICAN CONTINENTAL ANCESTRY GROUP; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH PERSONNEL; HEALTH SURVEYS; HISPANIC AMERICANS; HUMANS; INSURANCE COVERAGE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; SOCIAL CLASS; UNITED STATES; VACCINATION;

EID: 84872532748     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2011.300600     Document Type: Review

References (31)

1. Bryer J. Human papillomavirus health policy. Policy Polit Nurs Pract. 2010;11(1):23-28.
2. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813-819. (Pubitemid 46333946)
3. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices. Quadrivalent HPV. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1-24.
4. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(32):1018-1023.
5. US Department of Health and Human Services. 2020 topics and objectives: sexually transmitted diseases. Available at: http://healthypeople.gov/2020/ topics objectives2020/overview.aspx?topicid=37. Accessed June 2, 2011.
6. Bednarczyk RA, Birkhead GS, Morse DL, Doleyres H, McNutt LA. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university. Vaccine. 2011;29(17):3138-3143.
7. Chi RC, Neuzil KM. The association of sociodemographic factors and patient attitudes on influenza vaccination rates in older persons. Am J Med Sci. 2004;327 (3):113-117. (Pubitemid 38316410)
8. Samoff E, Dunn A, VanDevanter N, Blank S, Weisfuse IB. Predictors of acceptance of hepatitis B vaccination in an urban sexually transmitted diseases clinic. Sex Transm Dis. 2004;31(7):415-420. (Pubitemid 38812924)
9. Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health. 2009;45(5):453-462.
10. Howlader N, Noone AM, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2008 [based on November 2010 SEER data submission, posted to the SEER Web site]. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2008. Accessed May 27, 2011.
11. Health Indicators Warehouse. Invasive uterine cervical cancer (per 100,000). Available at: http://www.health indicators.gov/Indicators/ Invasiveuterinecervicalcancer-510/Profile/Data. Accessed May 27, 2011.
12. Centers for Disease Control and Prevention. National Immunization Survey-Teen: a user's guide for the 2009 public use data file. Available at: ftp://ftp.cdc.gov/pub/Health-Statistics/NCHS/Dataset-Documentation/NIS/ NISTEENPUF09-DUG.pdf. Accessed June 2, 2011.
13. Boehmke FJ, Skinner P. The determinants of state policy innovativeness. Paper prepared for presentation at the 2011 Midwest Political Science Association Meeting March 31-April 3, 2011. Available at: http://myweb. uiowa.edu/bhlai/workshop/bp.pdf. Accessed June 2, 2011.
14. Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008;43(3):239-245.
15. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine. 2011;29(5):890-895.
16. Litton AG, Desmond RA, Gilliland J, Huh WK, Franklin FA. Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama. J Pediatr Adolesc Gynecol. 2011;24(3):166-171 [Epub ahead of print 2011 Mar 12].
17. Guerry SL, De Rosa CJ, Markowitz LE, et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine. 2011;29(12):2235-2241.
18. Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009;45(5):528-531.
19. Bendik MK, Mayo RM, Parker VG. Knowledge, perceptions, and motivations related to HPV vaccination among college women. J Cancer Educ. 2011;26(3):459-464.
20. Brewer NT, Gottlieb SL, Reiter PL, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38(3):197-204.
21. Schluterman N, Terplan MS, Lydecker AD, Tracy JK. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine. 2011;29 (21):3767-3772 [Epub ahead of print 2011 Apr 6].
22. Stevens GD, Shi L. Primary care access and quality: two sides of the same coin. Arch Pediatr Adolesc Med. 2004;158(2):185.
23. Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;(Spec No.): 80-94.
24. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2-3):107-114. (Pubitemid 47348081)
25. Lechuga J, Swain G, Weinhardt LS. Perceived need of a parental decision aid for the HPV vaccine: content and format preferences. Health Promot Pract. 2011;13 (2):214-221[Epub ahead of print 2011 Mar 28].
26. Cardarelli R, Cardarelli KM. Recommendations for primary care physicians to improve HPV vaccination rates during clinical encounters. Osteopath Med Prim Care. 2008;2:10.
27. Adams M, Jasani B, Fiander A. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine. 2007;25(16):3007-3013. (Pubitemid 46482732)
28. Taylor LD, Hariri S, Sternberg M, Dunne EF, Markowitz LE. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev Med. 2011;52 (5):398-400.
29. US Department of Health and Human Services. Vaccines for Children Program. Available at: http://www.cdc.gov/vaccines/programs/vfc/default.htm. Accessed June 2, 2011.
30. Saha S, Komaromy M, Koepsell TD, Bindman AB. Patient-physician racial concordance and the perceived quality and use of health care. Arch Intern Med. 1999; 159(9):997-1004. (Pubitemid 29222501)
31. US Department of Health and Human Services. Media Advisory: ACIP recommends all 11-12 year-old males get vaccinated against HPV. Available at: http://www.cdc.gov/media/releases/2011/a1025-ACIP-HPV-Vote.html. Accessed December 2, 2011.